Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) shares reached a new 52-week high during trading on Wednesday . The company traded as high as GBX 62.50 and last traded at GBX 60.75, with a volume of 53833 shares changing hands. The stock had previously closed at GBX 55.
Beximco Pharmaceuticals Trading Up 10.5%
The company has a market cap of £271.01 million, a price-to-earnings ratio of 0.03 and a beta of 0.25. The company has a quick ratio of 0.37, a current ratio of 4.13 and a debt-to-equity ratio of 5.27. The business’s fifty day simple moving average is GBX 52.12 and its two-hundred day simple moving average is GBX 45.89.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Further Reading
- Five stocks we like better than Beximco Pharmaceuticals
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
